Filing Details
- Accession Number:
- 0001415889-25-011796
- Form Type:
- 13G Filing
- Publication Date:
- 2025-05-01 20:00:00
- Filed By:
- Samuel D. Tweardy
- Company:
- Tvardi Therapeutics Inc. (NASDAQ:TVRD)
- Filing Date:
- 2025-05-02
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
---|---|---|---|
Samuel D. Tweardy | 0 | 946,974 | 10.1% |
Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
TVARDI THERAPEUTICS, INC. (Name of Issuer) |
Common Stock, par value $0.001 per share (Title of Class of Securities) |
140755208 (CUSIP Number) |
04/15/2025 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | 140755208 |
1 | Names of Reporting Persons
Samuel D. Tweardy | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
946,974.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
10.1 % | ||||||||
12 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
TVARDI THERAPEUTICS, INC. | |
(b) | Address of issuer's principal executive offices:
3 Sugar Creek Ctr Blvd, Suite 525, Sugar Land, TX, 77478. | |
Item 2. | ||
(a) | Name of person filing:
Samuel D. Tweardy | |
(b) | Address or principal business office or, if none, residence:
535 Harold Avenue NE
Atlanta, GA 30307 | |
(c) | Citizenship:
United States | |
(d) | Title of class of securities:
Common Stock, par value $0.001 per share | |
(e) | CUSIP No.:
140755208 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
Row 9 of the Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by the Reporting Person and is incorporated by reference.
The Reporting Person's ownership of the Issuer's securities consists of (i) 315,658 shares of common stock directly held by Benjamin John Tweardy 2020 Gift Trust, of which the Reporting Person is the trustee; (ii) 315,658 shares of common stock directly held by Daniel James Tweardy 2020 Gift Trust, of which the Reporting Person is the trustee; and (iii) 315,658 shares of common stock directly held by Samuel David Tweardy 2020 Gift Trust, of which the Reporting Person is the trustee.
| |
(b) | Percent of class:
Row 11 of the Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by the Reporting Person and is incorporated by reference. The percentage set forth in each row 11 is based upon 9,355,542 shares of the Issuer's common stock outstanding as of April 15, 2025, as reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on April 15, 2025. | |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
Row 5 of the Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by the Reporting Person and is incorporated by reference. | ||
(ii) Shared power to vote or to direct the vote:
Row 6 of the Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by the Reporting Person and is incorporated by reference. | ||
(iii) Sole power to dispose or to direct the disposition of:
Row 7 of the Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by the Reporting Person and is incorporated by reference. | ||
(iv) Shared power to dispose or to direct the disposition of:
Row 8 of the Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by the Reporting Person and is incorporated by reference. | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|